Intellia Therapeutics's three largest insider shareholders as of May 14, 2026 are Fred E Cohen (Director, 207.45K shares), Edward J Iii Dulac (Evp, Chief Financial Officer, 160.96K shares), James Basta (Evp, General Counsel, 156.79K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Fred E Cohen | - | 207,453 | 0 | 07 Jan, 2026 |
| Edward J Iii Dulac | Evp, Chief Financial Officer | 160,963 | 0 | 03 Mar, 2026 |
| James Basta | Evp, General Counsel | 156,794 | 0 | 03 Mar, 2026 |
| Birgit C Schultes | Evp, Chief Scientific Officer | 137,733 | 0 | 03 Mar, 2026 |
| William J Chase | - | 134,693 | 0 | 22 Aug, 2025 |
| David Lebwohl | Evp, Chief Medical Officer | 131,192 | 0 | 03 Mar, 2026 |
| Eliana Clark | Evp, Chief Technical Officer | 93,864 | 0 | 03 Mar, 2026 |
| Michael P Dube | Vp, Chief Accounting Officer | 69,527 | 0 | 03 Mar, 2026 |
| Glenn Goddard | Evp, Chief Financial Officer | 69,213 | 0 | 05 Mar, 2024 |
| Derek Hicks | Evp, Chief Business Officer | 59,878 | 0 | 07 Jan, 2025 |
| Muna Bhanji | - | 27,203 | 0 | 13 Jun, 2025 |
| Frank Verwiel | - | 25,948 | 0 | 13 Jun, 2025 |
| Jesse Goodman | - | 24,359 | 0 | 02 Jul, 2025 |
| Brian Goff | - | 23,409 | 0 | 13 Jun, 2025 |
| Caroline Dorsa | - | 12,701 | 0 | 16 Jun, 2022 |
| John F Crowley | - | 11,716 | 0 | 16 Jun, 2023 |
| Jean Francois Formela | - | 7,291 | 0 | 16 Jun, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 01 Mar, 2026 | Edward J Iii Dulac | Common Stock | A | 61,280 | $0.00 | 160,963 | D | A |
| 01 Mar, 2026 | Birgit C Schultes | Common Stock | A | 39,200 | $0.00 | 137,733 | D | A |
| 01 Mar, 2026 | David Lebwohl | Common Stock | A | 9,943 | $0.00 | 131,192 | D | A |
| 01 Mar, 2026 | Michael P Dube | Common Stock | A | 17,250 | $0.00 | 69,527 | D | A |
| 01 Mar, 2026 | Eliana Clark | Common Stock | A | 7,353 | $0.00 | 94,471 | D | A |
| 01 Mar, 2026 | James Basta | Common Stock | A | 46,080 | $0.00 | 158,005 | D | A |
| 01 Mar, 2026 | Edward J Iii Dulac | Stock Option (right to buy) | A | 87,543 | $0.00 | 87,543 | D | A |
| 01 Mar, 2026 | David Lebwohl | Stock Option (right to buy) | A | 14,204 | $0.00 | 14,204 | D | A |
| 02 Mar, 2026 | James Basta | Common Stock | D | 1,211 | $13.78 | 156,794 | D | S |
| 01 Mar, 2026 | Birgit C Schultes | Stock Option (right to buy) | A | 56,000 | $0.00 | 56,000 | D | A |
| 02 Mar, 2026 | Eliana Clark | Common Stock | D | 607 | $13.78 | 93,864 | D | S |
| 01 Mar, 2026 | James Basta | Stock Option (right to buy) | A | 65,829 | $0.00 | 65,829 | D | A |
| 01 Mar, 2026 | Eliana Clark | Stock Option (right to buy) | A | 10,505 | $0.00 | 10,505 | D | A |
| 05 Jan, 2026 | James Basta | Common Stock | D | 10,397 | $9.21 | 101,528 | D | S |
| 05 Jan, 2026 | Edward J Iii Dulac | Common Stock | D | 6,379 | $9.21 | 99,683 | D | S |
| 05 Jan, 2026 | Birgit C Schultes | Common Stock | D | 8,508 | $9.21 | 98,533 | D | S |
| 05 Jan, 2026 | Eliana Clark | Common Stock | D | 9,515 | $9.21 | 87,118 | D | S |
| 05 Jan, 2026 | David Lebwohl | Common Stock | D | 11,903 | $9.21 | 121,249 | D | S |
| 05 Jan, 2026 | Michael P Dube | Common Stock | D | 2,989 | $9.21 | 52,277 | D | S |
| 05 Jan, 2026 | Fred E Cohen | Common Stock | A | 150,000 | $9.35 | 207,453 | D | P |